Are You the Next Scientific Director of CIHR’s Institute of Cancer Research?
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This position is for a research leader and champion who will support health research and knowledge mobilization at the highest level of scientific excellence.
Recognizing that the original deadline fell on September 30, the National Day for Truth and Reconciliation, CIHR has extended the application deadline to October 4, 2021. For more information, click here.
New Member to the CCRA Board
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »
$473M Invested in Cancer Research in 2016
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av... Read More »
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av... Read More »